Trajan Group Holdings
Trajan Group Holdings develops and manufactures analytical and life sciences instruments and devices. The company focuses on creating solutions for biological, environmental, and food-related measurements, aiming to improve personal health through scientific tools. Trajan partners in producing critical components and materials for analytical workflow and measurement.
Short position
Trajan Group Holdings (ASX:TRJ) has 0.00% of its shares on issue reported as short positions as of 17 July 2026, or about 1,406 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. TRJ is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Trajan Group Holdings (TRJ) Short Interest
Trajan Group Holdings (ASX:TRJ) had 0.00% of shares reported as short positions as of 17 July 2026, representing 1,406 shares. Trajan Group Holdings operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Short interest
History & FAQ →Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.
Strategy fit
How each stock picker strategy reads TRJ today
- Zanger BreakoutNot a candidate
- CAN SLIMNot a candidate
- Minervini Trend TemplateWatchScore 18rank 1049 of 1764
- Crowded-Short BreakoutNot a candidate
- Quality compoundersNot a candidate
Prices to 9 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →
TRJ fundamentals
In the year to 30 Jun 2026, Trajan Group Holdings (ASX:TRJ) recorded revenue of A$161.4M and a net loss after tax of A$623.0K. A year earlier it recorded revenue of A$166.5M and a net loss after tax of A$4.5M. Year-on-year growth: revenue −3.1% (FY). Net margin −0.4%, return on equity −0.6% (FY). Figures are in AUD, the company's reporting currency; source: Yahoo Finance, as at 29 Sep 2026.
Full statements, ratios and filings are on the Financials tab. Not financial advice.
Latest TRJ news
All news- Is Trajan Group Turning the Corner After Its Update (ASX:TRJ)?
kalkine · 8 Oct 2026
- Trajan Group Heading into New Financial Year With Earnings Momentum
smallcaps · 7 Oct 2026
- Trajan ShareWise Webinar, Introduction and Trading Update
asx · 7 Oct 2026
About
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Be the first to discuss TRJ
Start a research thread or post the first pulse update